France Reports First Human Case and Fatality of Shamonda Virus

French health authorities confirmed on Thursday that the first known human case of the Shamonda virus has been detected in a patient who died at a Lyon hospital in early October. Officials described the event as an exceptional case involving a severely immunocompromised individual, emphasizing that there is currently no risk to the general public.

According to reports from the French health and agriculture ministries, the patient likely contracted the orthobunyavirus through a midge bite while in eastern France. The region is the same area where the virus was first discovered circulating among animals earlier in the spring and summer of 2026.

Medical evaluations indicated that the patient experienced neurological and cerebral complications before passing away. Authorities noted that these complications were very likely linked to the virus infection, though ongoing clinical, biological, and epidemiological investigations continue to determine the exact extent to which the virus caused or contributed to the death.

The Shamonda virus is an insect-borne pathogen primarily spread by biting midges of the genus Culicoides. Until now, the disease was known to affect livestock such as cattle, horses, alpacas, sheep, and goats, but had never before been documented in human beings since its initial discovery in Nigeria in the mid-1960s.

Following decades of sporadic detection in parts of Africa and Japan, the virus was confirmed in Europe for the first time in late July. Genomic tests on sick cattle revealed its presence in southern Germany, Switzerland, and eastern France, alongside subsequent reports in numerous other European nations including Austria, Belgium, Ireland, Italy, the Netherlands, Spain, and the United Kingdom's Jersey.

In infected livestock, the virus typically manifests through symptoms such as fever, loss of appetite, abdominal discomfort, diarrhea, and a sharp decline in milk production for dairy cows. The World Organisation for Animal Health noted that there are currently no commercially available vaccines against the Shamonda virus.

International health organizations, including the World Health Organization and the European Centre for Disease Prevention and Control, have been notified of the development. The ECDC stated that it is closely monitoring the situation and collaborating with French authorities and European partners to evaluate the potential public health implications of this unprecedented human transmission.